General Information

Targeting Microbiota 2016 - Preliminary Agenda

4th World Congress on

Targeting Microbiota 

Towards Clinical Revolution

October 17-19, 2016 - Institut Pasteur - Paris, France

Preliminary Agenda

Among speakers already confirmed:

Bioinformatics, integrating clinical and microbiome data: the challenge.
Examples from gut, oral and nasal microbiota in Parkinson’s disease
Velma Aho, University of Helsinki, Finland

Transition from an infant- to adult-like gut microbiota – where do the bacteria come from?
Ekaterina Avershina, Norway University of Life Sciences, Norway

Changing of skin and gut Microbiotas in ordinary life: cosmetics and bowel
Lorenzo Drago, University of Milan, Italy

Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Paul Forsythe, McMaster University, Canada

Age-related immune senescence and microbiota dysbiosis: lessons from the fly
Henri Jasper, University of Rochester, USA

Impact of microbiota on odorant detection and olfactory preferences in mice
Nicolas Meunier, Neurobiologie de l'Olfaction et Blosenseur (NBO), INRA

Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
Andrés Moya, University of Valencia, Spain

Faecalibacterium prausnitzii dynamics in the human gut microbiome underlying atopic dermatitis
Heenam Stanley Kim, Korea University, Republic of Korea

Maternal microbiota sets neonatal innate immune system development
Mercedes Gomez de Agüero, University of Bern, Switzerland

Microbiota & Bioinformatics: Strategic Targets
Sean Kennedy, Institut Pasteur, Paris

Emerging role of fecal microbiota therapy in the treatment of gastrointestinal diseases
Peter C. Konturek, Thuringia-Clinic Saalfeld, Germany

Lactobacillus rhamnosus GG intake modifies preschool children’s intestinal microbiota, alleviates penicillin-associated changes and reduces antibiotic use
Katri Korpela, Helsinki University, Finland

Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Roberto Pacifici, Emory University School of Medicine, USA

Tools and approaches to achieve strain resolution analyses of the microbiota
The gut microbiota mobilome and the potential of pathogen transmission of antibiotic resistance
Knut Rudi, Norway University of Life Sciences, Norway

Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: Pitfalls and promises from a first meta-analysis
Franco Scaldaferri, Catholic University of Sacred Hearth, Italy

Bacteriophages for improving human health: from food additives to dietary supplements
Alexander Sulakvelidze, Intralytix, USA

Mammals shape their microbiome to prevent disease: Recent Scientific advances & Perspectives
Howard Weiner, Harvard Medical School, USA

Important human microbial ecological system modulator - FMT (fecal microorganism transplantation) or one of the best clinical applications of epigenetics in gastroenterology
Diana Zandere, University of Riga, Latvia

Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection
Juan-Jose Quereda, Institut Pasteur, France

Response of gut bacteria to host starvation: understanding the risk factos to develop an eating disorder
Serguei Fetissov, Rouen University, France

Day 1 - October 17

Session 1: Microbiota 2016: Recent Advances & Perspectives

• Mechanistics
• Cellular & Molecular Impacts
• Microbiota & Immunity: The subtle balance
• Microbiota & Mitochondria: The intriguing relationship

Session 2: Microbiota analysis 2016: The challenge of big data interpretation

• How to manage the big data?
• Focus 2016: Strategic role of bio-informaticians to interpret the results
• Microbiota & Bioinformatics: Strategic targets

Session 3: Skin Microbiota: Recent advances and perspectives

Day 2 - October 18

Session 4: Challenges to control the diversity and variability of microbiota by:

• Phage therapy
• Diet, probiotics and prebiotics
• CRISPR/Cas system
• Quorum sensing
• Fecal Microbiota Transplantation

Day 3 - October 19

Focus on Fecal Microbiota Transplantation: Clinical & Practical Issues

Session 5: Microbiota & Clinical Studies: Recent results

The details of each session will be available soon.

To access to the list of speakers already confirmed, please click here.